# Innate Pharma, SA — Form D

Innate Pharma, SA of MARSEILLE, I0, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-31. The offering totals $27.4M, of which $27.4M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2014-01-31
- Form: D
- Accession: 0001598599-14-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $27.4M
- Amount sold: $27.4M
- Investors: 6
- Date of first sale: 2013-11-19
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-211065

## Issuer

- Name: Innate Pharma, SA
- CIK: 0001598599
- Entity type: Limited Liability Company
- Jurisdiction: FRANCE
- Address: 117 AVENUE DE LUMINY, MARSEILLE, I0, 13009
- Phone: 01133430303030

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Herve BRAILLY | Executive Officer | Marseille, I0 |

## More

- [CIK 1598599 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1598599&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001598599-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.